IDRA - Idera Pharmaceuticals, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow

Income Statement

Annual
All numbers in thousands
Revenue12/31/201812/31/201712/31/201612/31/2015
Total Revenue66290216,199249
Cost of Revenue26,03519,42115,72913,242
Gross Profit-25,373-18,519470-12,993
Operating Expenses
Research Development15,80625,65524,09520,457
Selling General and Administrative15,42015,58815,13215,396
Non Recurring----
Others----
Total Operating Expenses57,26160,66454,95649,095
Operating Income or Loss-56,599-59,762-38,757-48,846
Income from Continuing Operations
Total Other Income/Expenses Net-3,282-6,222368291
Earnings Before Interest and Taxes-56,599-59,762-38,757-48,846
Interest Expense-11-50-80-105
Income Before Tax-59,881-65,984-38,389-48,555
Income Tax Expense----
Minority Interest----
Net Income From Continuing Ops-59,881-65,984-38,389-48,555
Non-recurring Events
Discontinued Operations----
Extraordinary Items----
Effect Of Accounting Changes----
Other Items----
Net Income
Net Income-59,881-65,984-38,389-48,555
Preferred Stock And Other Adjustments----
Net Income Applicable To Common Shares-59,881-65,984-38,389-48,555